BMC Cancer
(Jun 2023)
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
- Shogo Amano,
- Seiji Kaino,
- Shuhei Shinoda,
- Hirofumi Harima,
- Toshihiko Matsumoto,
- Koichi Fujisawa,
- Taro Takami,
- Naoki Yamamoto,
- Takahiro Yamasaki,
- Isao Sakaida
Affiliations
- Shogo Amano
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Seiji Kaino
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Shuhei Shinoda
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Hirofumi Harima
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Toshihiko Matsumoto
- Department of Oncology and Laboratory Medicine, Graduate School of Medicine, Yamaguchi University
- Koichi Fujisawa
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Taro Takami
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Naoki Yamamoto
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- Takahiro Yamasaki
- Department of Oncology and Laboratory Medicine, Graduate School of Medicine, Yamaguchi University
- Isao Sakaida
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
- DOI
-
https://doi.org/10.1186/s12885-023-11091-y
- Journal volume & issue
-
Vol. 23,
no. 1
pp.
1
– 2
WeChat QR code
